Have a feature idea you'd love to see implemented?
Let us know!
REVB Revelation Biosciences Inc
Price (delayed)
$0.84
Market cap
$1.38M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$33.62
Enterprise value
-$10.69M
Highlights
The EPS has dropped by 108% year-on-year but it rose by 2% since the previous quarter
REVB's equity has dropped by 90% year-on-year and by 88% since the previous quarter
The net income has shrunk by 77% QoQ
Key stats
What are the main financial stats of REVB
Market
Valuations
Earnings
Shares outstanding
1.64M
Market cap
$1.38M
Enterprise value
-$10.69M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.2
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$15.9M
EBITDA
-$15.88M
Free cash flow
-$9.06M
Per share
Balance sheet
Liquidity
EPS
-$33.62
Free cash flow per share
-$5.54
Book value per share
$0.7
Revenue per share
$0
TBVPS
$7.5
Total assets
$12.27M
Total liabilities
$11.13M
Debt
$0
Equity
$1.14M
Working capital
$1.07M
Debt to equity
0
Current ratio
1.1
Quick ratio
1.08
Net debt/EBITDA
0.76
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-119.1%
Return on equity
-243.9%
Return on invested capital
N/A
Return on capital employed
-1,394.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
REVB stock price
How has the Revelation Biosciences stock price performed over time
Intraday
-1.18%
1 week
-1.16%
1 month
13.51%
1 year
-95.73%
YTD
-94.41%
QTD
-1.39%
Financial performance
How have Revelation Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.53M
Net income
-$15.9M
Gross margin
N/A
Net margin
N/A
The net income has shrunk by 77% QoQ
REVB's operating income has plunged by 60% YoY and by 7% from the previous quarter
Growth
What is Revelation Biosciences's growth rate over time
Valuation
What is Revelation Biosciences stock price valuation
P/E
N/A
P/B
1.2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 108% year-on-year but it rose by 2% since the previous quarter
REVB's equity has dropped by 90% year-on-year and by 88% since the previous quarter
The price to book (P/B) is 20% higher than the last 4 quarters average of 1.0
Efficiency
How efficient is Revelation Biosciences business performance
REVB's return on equity has dropped by 147% since the previous quarter
The company's return on assets has shrunk by 90% QoQ
Dividends
What is REVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for REVB.
Financial health
How did Revelation Biosciences financials performed over time
The company's total assets is 10% higher than its total liabilities
Revelation Biosciences's total liabilities has soared by 141% YoY and by 113% from the previous quarter
The company's current ratio has shrunk by 68% YoY and by 61% QoQ
The debt is 100% less than the equity
REVB's equity has dropped by 90% year-on-year and by 88% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.